Finance

Lists
Q3 2026 earnings • released • EPS beat +8,76% • Revenue beat +0,94%
See results
6446:TPE
PharmaEssentia Corp
NT$1 380,00
+1,10%
(+15,00) 1D
13 Nov., 13:30:31 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6446...
Open
NT$1 375,00
High
NT$1 405,00
Low
NT$1 370,00
Mkt. cap
582,96 mjd
Avg. vol.
2,65 m
Volume
3,70 m
Dividend
0,10%
Quarterly dividend
NT$0,34
Ex-dividend date
09 Jul. 2026
P/E ratio
77,09
52-wk high
NT$1 645,00
52-wk low
NT$407,92
EPS
NT$17,90
No. of employees
131
Open
NT$1 375,00
High
NT$1 405,00
Low
NT$1 370,00
Mkt. cap
582,96 mjd
Avg. vol.
2,65 m
Volume
3,70 m
Dividend
0,10%
Quarterly dividend
NT$0,34
Ex-dividend date
09 Jul. 2026
P/E ratio
77,09
52-wk high
NT$1 645,00
52-wk low
NT$407,92
EPS
NT$17,90
No. of employees
131
News stories
From web sources and news partners
About PharmaEssentia Corp
CEO-
Employees131
Founded09 Mei 1990
Headquarters-
SectorHealth Care
Industry-
Websitepharmaessentia.com
Last report
11 Nov. 2026
Fiscal period
Q3 2026
NT$7,08 / NT$6,51
+8,76%beat
Revenue / Est. (TWD)
7,76 mjd / 7,69 mjd
+0,94%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
4,88 mjd
5,12 mjd
6,86 mjd
7,76 mjd
Cost of goods sold
543,68 m
621,28 m
395,45 m
245,13 m
Cost of revenue
543,68 m
621,28 m
395,45 m
245,13 m
Research and development expenses
1,01 mjd
857,29 m
1,07 mjd
1,22 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,77 mjd
1,56 mjd
2,24 mjd
3,16 mjd
Operating expense
2,78 mjd
2,41 mjd
3,31 mjd
4,39 mjd
Total operating expenses
3,32 mjd
3,03 mjd
3,70 mjd
4,63 mjd
Operating income
1,56 mjd
2,09 mjd
3,15 mjd
3,13 mjd
Other non operating income
4,37 m
1,32 m
8,58 m
-7,94 m
EBT including unusual items
2,01 mjd
2,34 mjd
3,20 mjd
3,25 mjd
EBT excluding unusual items
2,01 mjd
2,34 mjd
3,20 mjd
3,25 mjd
Income tax expense
536,45 m
185,95 m
668,64 m
329,44 m
Effective tax rate
26,65%
7,96%
20,90%
10,13%
Other operating expenses
-
-
-
-
Net income
1,48 mjd
2,15 mjd
2,53 mjd
2,92 mjd
Net profit margin
30,24%
41,97%
36,90%
37,67%
Earnings per share
3,58
5,21
6,13
7,08
Interest and investment income
142,46 m
139,53 m
148,04 m
142,64 m
Interest expense
-5,76 m
-4,71 m
-5,95 m
-8,23 m
Net interest expenses
136,70 m
134,82 m
142,08 m
134,41 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,60 mjd
2,14 mjd
3,21 mjd
3,41 mjd
Gain or loss from assets sale
1,50 m
-
-
82,00 k
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme